Ledger.Open graph →
SEC Form D · filed December 29, 2025

Aprea Therapeutics, Inc

Offering
$5.8M
Sold
$3.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DOYLESTOWN, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Oren Gilad · Doylestown, PAExec · DirectorJean-Pierre P. Bizzari · Doylestown, PADirectorRifat B. Pamukcu · Doylestown, PADirectorBernd B. Seizinger · Doylestown, PADirectorMichael P. Grissinger · Doylestown, PADirectorPeter J. Ogren · Burlington, MAExec · DirectorJohn P. Hamill · Madison, WIExecGabriela P. Gruia · Doylestown, PADirectorMarc P. Duey · Doylestown, PADirectorJohn B. Henneman · Austin, TXDirectorRichard P. Peters · Doylestown, PADirectorLou D. Canakes Ii · New York, NYExec · DirectorJohn P. Hamill · Madison, WIExecJean-Pierre P. Bizzari · Doylestown, PADirectorGabriela P. Gruia · Doylestown, PADirectorRifat B. Pamukcu · Doylestown, PADirectorBernd B. Seizinger · Doylestown, PADirectorMarc P. Duey · Doylestown, PADirectorJohn B. Henneman · Austin, TXDirectorMichael P. Grissinger · Doylestown, PADirectorRichard P. Peters · Doylestown, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗